Sionna Therapeutics (SION) Stock Insights
$183.99M
Market Cap
—
P/E
—
Forward P/E
—
Score
SION price $4.08 +0.20 +5.30%
SION fair value Not meaningful. Price $4.08.
Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.
Not meaningful
| Date | EPS actual | EPS estimate | Revenue | Revenue estimate |
|---|---|---|---|---|
| 2026-11-04 | — | -0.64 | — | — |
| 2026-08-06 | -0.66 | -0.65 | — | — |
| 2026-05-12 | -0.60 | -0.52 | — | — |
| 2026-03-02 | -0.46 | -0.54 | — | — |
| 2025-11-05 | -0.46 | -0.52 | — | — |
| 2025-08-11 | -0.41 | -0.68 | — | — |
| 2025-05-12 | -0.62 | -0.45 | — | — |
| 2025-03-20 | -3.38 | -1.28 | — | — |
| 2025-01-17 | -0.92 | — | — | — |
Yield 0.00%. Payout ratio 0.00%. Frequency —.
Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.
| Ex-date | Dividend | Record | Payment | Frequency |
|---|---|---|---|---|
| No data yet. | ||||
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-09-17 | RA CAPITAL MANAGEMENT, L.P. | Sell | 3.42M | $6.32 | 21.58M |
| 2026-09-17 | RA CAPITAL MANAGEMENT, L.P. | Sell | 33.80K | $7.46 | 252.15K |
| 2026-09-17 | Ridloff Elena | Buy | 165.44K | $7.18 | 1.19M |
| 2026-09-17 | Ridloff Elena | Buy | 47.27K | — | — |
| 2026-09-17 | Ridloff Elena | Buy | 47.27K | — | — |
| 2026-09-17 | Ridloff Elena | Sell | 165.44K | $39.21 | 6.49M |
| 2026-09-17 | McKee Charlotte | Buy | 155.70K | $7.18 | 1.12M |
| 2026-09-17 | McKee Charlotte | Buy | 50.00K | — | — |
| 2026-09-17 | McKee Charlotte | Buy | 50.00K | — | — |
| 2026-09-17 | McKee Charlotte | Sell | 155.70K | $39.21 | 6.10M |
| 2026-09-17 | Fitzpatrick Jennifer | Buy | 103.14K | $7.18 | 740.55K |
| 2026-09-17 | Fitzpatrick Jennifer | Buy | 28.13K | — | — |
| 2026-09-17 | Fitzpatrick Jennifer | Buy | 28.13K | — | — |
| 2026-09-17 | Fitzpatrick Jennifer | Sell | 103.14K | $39.21 | 4.04M |
| 2026-09-17 | Cloonan Michael | Buy | 109.03K | — | — |
| 2026-09-17 | Cloonan Michael | Buy | 109.03K | — | — |
| 2026-09-17 | Cloonan Michael | Buy | 436.10K | $7.18 | 3.13M |
| 2026-09-17 | Cloonan Michael | Sell | 436.10K | $39.21 | 17.10M |
| 2026-07-07 | Thompson Peter A. | Sell | 85.92K | $44.86 | 3.85M |
| 2026-07-07 | ORBIMED ADVISORS LLC | Sell | 85.92K | $44.86 | 3.85M |
| 2026-07-06 | Fitzpatrick Jennifer | Sell | 10.25K | $6.11 | 62.63K |
| 2026-07-06 | Fitzpatrick Jennifer | Buy | 10.25K | $6.11 | 62.63K |
| 2026-07-06 | Fitzpatrick Jennifer | Sell | 10.25K | $43.60 | 446.86K |
| 2026-06-30 | Thompson Peter A. | Sell | 115.84K | $45.50 | 5.27M |
| 2026-06-30 | ORBIMED ADVISORS LLC | Sell | 115.84K | $45.50 | 5.27M |
| 2026-06-17 | Stelzer Laurie | Buy | 17.34K | $36.73 | 636.90K |
| 2026-06-17 | Viney Joanne L. | Buy | 17.34K | $36.73 | 636.90K |
| 2026-06-17 | Thompson Peter A. | Buy | 17.34K | $36.73 | 636.90K |
| 2026-06-17 | RA CAPITAL MANAGEMENT, L.P. | Buy | 17.34K | $36.73 | 636.90K |
| 2026-06-17 | Ruddy Marcella K. | Buy | 17.34K | $36.73 | 636.90K |
| 2026-06-17 | Resnick Joshua | Buy | 17.34K | $36.73 | 636.90K |
| 2026-06-17 | Fleming Harold Edward | Buy | 17.34K | $36.73 | 636.90K |
| 2026-06-17 | Clancy Paul J | Buy | 17.34K | $36.73 | 636.90K |
| 2026-06-17 | Booth Bruce | Buy | 17.34K | $36.73 | 636.90K |
| 2026-05-27 | Thompson Peter A. | Sell | 101 | $44.49 | 4.49K |
| 2026-05-27 | ORBIMED ADVISORS LLC | Sell | 101 | $44.49 | 4.49K |
| 2026-05-11 | Thompson Peter A. | Sell | 184.64K | $46.22 | 8.53M |
| 2026-05-11 | ORBIMED ADVISORS LLC | Sell | 184.64K | $46.22 | 8.53M |
| 2026-05-08 | Thompson Peter A. | Sell | 59.77K | $44.58 | 2.66M |
| 2026-05-08 | ORBIMED ADVISORS LLC | Sell | 59.77K | $44.58 | 2.66M |
| 2026-05-07 | Thompson Peter A. | Sell | 48.55K | $44.61 | 2.17M |
| 2026-05-07 | ORBIMED ADVISORS LLC | Sell | 48.55K | $44.61 | 2.17M |
| 2026-04-18 | Thompson Peter A. | Sell | 2.95K | $44.52 | 131.24K |
| 2026-04-18 | ORBIMED ADVISORS LLC | Sell | 2.95K | $44.52 | 131.24K |
| 2026-04-17 | Thompson Peter A. | Sell | 52.40K | $44.68 | 2.34M |
| 2026-04-17 | ORBIMED ADVISORS LLC | Sell | 52.40K | $44.68 | 2.34M |
| 2026-04-16 | Thompson Peter A. | Sell | 226.91K | $45.34 | 10.29M |
| 2026-04-16 | ORBIMED ADVISORS LLC | Sell | 226.91K | $45.34 | 10.29M |
| 2026-04-15 | Thompson Peter A. | Sell | 235.86K | $44.64 | 10.53M |
| 2026-04-15 | ORBIMED ADVISORS LLC | Sell | 235.86K | $44.64 | 10.53M |
| 2026-04-14 | Thompson Peter A. | Sell | 47.81K | $44.51 | 2.13M |
| 2026-04-14 | ORBIMED ADVISORS LLC | Sell | 47.81K | $44.51 | 2.13M |
| 2026-03-05 | Fitzpatrick Jennifer | Sell | 10.25K | $6.11 | 62.63K |
| 2026-03-05 | Fitzpatrick Jennifer | Buy | 10.25K | $6.11 | 62.63K |
| 2026-03-05 | Fitzpatrick Jennifer | Sell | 10.25K | $33.86 | 347.02K |
| 2026-02-03 | Thompson Peter A. | Sell | 29.06K | $44.58 | 1.30M |
| 2026-02-03 | ORBIMED ADVISORS LLC | Sell | 29.06K | $44.58 | 1.30M |
| 2026-02-02 | Thompson Peter A. | Sell | 1.89K | $44.57 | 84.24K |
| 2026-02-02 | ORBIMED ADVISORS LLC | Sell | 1.89K | $44.57 | 84.24K |
| 2026-01-22 | TPG GP A, LLC | Sell | 250.00K | $40.00 | 10.00M |
| 2026-01-02 | McKee Charlotte | Buy | 155.70K | $39.21 | 6.10M |
| 2026-01-02 | Fitzpatrick Jennifer | Buy | 103.14K | $39.21 | 4.04M |
| 2026-01-02 | Cloonan Michael | Buy | 436.10K | $39.21 | 17.10M |
| 2026-01-02 | Beer Caroline Stark | Buy | 139.34K | $39.21 | 5.46M |
| 2026-01-02 | Ridloff Elena | Buy | 165.44K | $39.21 | 6.49M |
| 2025-12-24 | ORBIMED ADVISORS LLC | Sell | 33.36K | $44.55 | 1.49M |
| 2025-12-24 | Thompson Peter A. | Sell | 33.36K | $44.55 | 1.49M |
| 2025-12-19 | ORBIMED ADVISORS LLC | Sell | 875 | $44.49 | 38.93K |
| 2025-12-19 | Thompson Peter A. | Sell | 875 | $44.49 | 38.93K |
| 2025-12-18 | ORBIMED ADVISORS LLC | Sell | 100 | $44.49 | 4.45K |
| 2025-12-18 | Thompson Peter A. | Sell | 100 | $44.49 | 4.45K |
| 2025-12-17 | ORBIMED ADVISORS LLC | Sell | 900 | $44.50 | 40.05K |
| 2025-12-17 | Thompson Peter A. | Sell | 900 | $44.50 | 40.05K |
| 2025-12-05 | Fitzpatrick Jennifer | Sell | 10.25K | $6.11 | 62.63K |
| 2025-12-05 | Fitzpatrick Jennifer | Buy | 10.25K | $6.11 | 62.63K |
| 2025-12-05 | Fitzpatrick Jennifer | Sell | 10.25K | $40.52 | 415.33K |
| 2025-11-26 | ORBIMED ADVISORS LLC | Sell | 1.60K | $44.49 | 71.18K |
| 2025-11-26 | Thompson Peter A. | Sell | 1.60K | $44.49 | 71.18K |
| 2025-11-25 | ORBIMED ADVISORS LLC | Sell | 11.89K | $44.60 | 530.29K |
| 2025-11-25 | Thompson Peter A. | Sell | 11.89K | $44.60 | 530.29K |
| 2025-11-24 | ORBIMED ADVISORS LLC | Sell | 94.58K | $44.54 | 4.21M |
| 2025-11-24 | Thompson Peter A. | Sell | 94.58K | $44.54 | 4.21M |
| 2025-11-21 | RA CAPITAL MANAGEMENT, L.P. | Sell | 1.21K | $39.50 | 47.80K |
| 2025-11-21 | RA CAPITAL MANAGEMENT, L.P. | Sell | 6.44K | $39.50 | 254.38K |
| 2025-11-21 | RA CAPITAL MANAGEMENT, L.P. | Sell | 9.92K | $39.50 | 392.00K |
| 2025-11-21 | RA CAPITAL MANAGEMENT, L.P. | Sell | 7.61K | $39.50 | 300.56K |
| 2025-11-20 | RA CAPITAL MANAGEMENT, L.P. | Sell | 150 | $39.89 | 5.98K |
| 2025-11-20 | RA CAPITAL MANAGEMENT, L.P. | Sell | 96 | $40.50 | 3.89K |
| 2025-11-20 | RA CAPITAL MANAGEMENT, L.P. | Sell | 801 | $39.89 | 31.95K |
| 2025-11-20 | RA CAPITAL MANAGEMENT, L.P. | Sell | 512 | $40.50 | 20.74K |
| 2025-11-20 | RA CAPITAL MANAGEMENT, L.P. | Sell | 1.24K | $39.89 | 49.26K |
| 2025-11-20 | RA CAPITAL MANAGEMENT, L.P. | Sell | 788 | $40.50 | 31.91K |
| 2025-11-20 | RA CAPITAL MANAGEMENT, L.P. | Sell | 947 | $39.89 | 37.78K |
| 2025-11-20 | RA CAPITAL MANAGEMENT, L.P. | Sell | 604 | $40.50 | 24.46K |
| 2025-11-19 | RA CAPITAL MANAGEMENT, L.P. | Sell | 2.28K | $40.01 | 91.06K |
| 2025-11-19 | RA CAPITAL MANAGEMENT, L.P. | Sell | 2 | $40.61 | 81 |
| 2025-11-19 | RA CAPITAL MANAGEMENT, L.P. | Sell | 12.13K | $40.01 | 485.16K |
| 2025-11-19 | RA CAPITAL MANAGEMENT, L.P. | Sell | 8 | $40.61 | 325 |
| 2025-11-19 | RA CAPITAL MANAGEMENT, L.P. | Sell | 18.68K | $40.01 | 747.55K |
| 2025-11-19 | RA CAPITAL MANAGEMENT, L.P. | Sell | 12 | $40.61 | 487 |
Latest filed quarter: Q2 2026.
Institutions holding: 157, holders +36 vs prior quarter. Ownership 106.79%.
| Holder | Shares | Change | Change % | Value |
|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 9.91M | 0 | 0.00% | 435.72M |
| TPG GP A, LLC | 6.49M | 0 | 0.00% | 285.71M |
| VIKING GLOBAL INVESTORS LP | 3.20M | 0 | 0.00% | 140.56M |
| ATLAS VENTURE LIFE SCIENCE ADVISORS, LLC | 3.00M | 0 | 0.00% | 131.78M |
| ORBIMED ADVISORS LLC | 2.56M | -974.83K | -27.61% | 112.43M |
| ENAVATE SCIENCES GP, LLC | 2.48M | 0 | 0.00% | 109.01M |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1.60M | 1.45M | +966.67% | 70.38M |
| BLACKROCK, INC. | 1.47M | 178.90K | +13.81% | 64.88M |
| JPMORGAN CHASE & CO | 1.49M | 25.49K | +1.74% | 64.09M |
| JENNISON ASSOCIATES LLC | 1.17M | -279.09K | -19.23% | 51.56M |
| CITADEL ADVISORS LLC | 1.15M | -19.30K | -1.65% | 50.48M |
| VANGUARD CAPITAL MANAGEMENT LLC | 1.13M | 102.50K | +9.96% | 49.80M |
| STATE STREET CORP | 1.02M | 265.31K | +35.08% | 44.94M |
| PERCEPTIVE ADVISORS LLC | 905.00K | 246.56K | +37.45% | 39.81M |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 680.92K | -289.67K | -29.85% | 29.95M |
| SIREN, L.L.C. | 610.51K | 310.51K | +103.50% | 26.86M |
| PRICE T ROWE ASSOCIATES INC /MD/ | 478.02K | -278.36K | -36.80% | 21.03M |
| EVENTIDE ASSET MANAGEMENT, LLC | 474.98K | -170.55K | -26.42% | 20.89M |
| GEODE CAPITAL MANAGEMENT, LLC | 457.14K | 67.27K | +17.26% | 20.11M |
| BAKER BROS. ADVISORS LP | 400.00K | 0 | 0.00% | 17.60M |
| CASDIN CAPITAL, LLC | 400.00K | 400.00K | New | 17.60M |
| GOLDMAN SACHS GROUP INC | 388.81K | 125.64K | +47.74% | 17.10M |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 385.45K | 308.81K | +402.98% | 16.96M |
| FRANKLIN TEMPLETON INC | 290.11K | 114.63K | +65.32% | 12.76M |
| ABERDEEN GROUP PLC | 284.14K | -280.04K | -49.64% | 12.50M |
Insights · Dividends · Forecast · Financials · Learn
$183.99M
Market Cap
—
P/E
—
Forward P/E
—
Score